Plexxikon Announces Preclinical Data Demonstrating Dramatic Improvement in Key Symptoms of...

                   
drugs.com     May 22, 2008            

BERKELEY, Calif.--(BUSINESS WIRE)--May 21, 2008 - Plexxikon Inc. today announced data from preclinical studies of Polycystic Kidney Disease (PKD) demonstrating significantly reduced kidney disease following treatment with Plexxikon's novel drug... ... BERKELEY,... [read full story]                    

Full Coverage
                   

Plexxikon Announces Preclinical Data Demonstrating Dramatic Improvement in Key Symptoms of...

genengnews.com     May 21, 2008          

News source: Business Wire Plexxikon Inc. today announced data from preclinical studies of Polycystic Kidney Disease (PKD) demonstrating significantly reduced kidney disease following treatment with Plexxikon's novel drug candidate. Plexxikon's novel small molecule kinase inhibitor is a highly...                    

comments

Plexxikon presents positive results from preclinical kidney disease study

pharmaceutical-business-review.com     May 23, 2008          

Plexxikon has announced positive data from preclinical studies of polycystic kidney disease demonstrating significantly reduced kidney disease following treatment with Plexxikon's novel drug candidate. In the preclinical study of Plexxikon's polycystic kidney disease (PKD) drug candidate, doses...                    

comments